Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of oral mucositis and radiation caries during head and neck cancer treatment
RBR-426p272Not yet recruiting
- Sponsor
- Faculdade de Odontologia de Araraquara
- Start
- Oct 2025
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, double-blind trial of nystatin, sodium fluoride and PRG Pro-Care Gel α in head and neck cancer (HNC) (3 arms), sponsored by Faculdade de Odontologia de Araraquara. Primary endpoint: Oral mucositis development. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
nystatinsodium fluoridePRG Pro-Care Gel α
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on RBR-426p272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-426p272.